Relation of circulating interleukin-6 to left ventricular remodeling in patients with reperfused anterior myocardial infarction

Clinical Cardiology

Volumn 27, Issue 7, 2004, Pages 417-420

  Ohtsuka, Tomoaki ^a   Hamada, Mareomi ^a   Inoue, Katsuji ^a   Ohshima, Kiyotaka ^a   Suzuki, Jun ^a   Matsunaka, Tsuyoshi ^a   Ogimoto, Akiyoshi ^a   Hara, Yuji ^a   Shigematsu, Yuji ^a   Higaki, Jitsuo ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokines; Left ventricular remodeling; Myocardial infarction

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE REMODELING; HEART VENTRICULOGRAPHY; HUMAN; INFLAMMATION; MALE;

EID: 3042763002     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960270712     Document Type: Article

References (21)

1. Erlebacher JA, Weisse JL, Weis feldt ML, Bulkley BH: Early dilatation of the infarcted segment in acute transmural myocardial infarction: Role of infarct expansion in acute left ventricular enlargement. J Am Coll Cardiol 1984;4:201-208
2. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications. Circulation 1990;81:1161-1172
3. Schuster EH, Bulkley BH: Expansion of transmural myocardial infarction: A pathophysiologic factor in cardiac rupture. Circulation 1979;60: 1532-1538
4. Jugdutt BI, Michorowski BL: Role of infarct expansion in rupture of the ventricular septum after acute myocardial infarction: A two dimensional echocardiographic study. Clin Cardiol 1987;10:641-652
5. Weisman HF, Bartow T, Leppo MK, Marsh HC Jr, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT: Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990; 249:146-151
6. Herskowitz A, Choi S, Ansari AA, Wesselingh S: Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 1995; 146:419-428
7. Hiasa G, Hamada M, Ikeda S, Hiwada K: Ischemic preconditioning and lipopolysaccharide attenuate nuclear factor-κB activation and gene expression of inflammatory cytokines in the ischemia-reperfused heart. Jpn Circ J 2001;65:984-990
8. Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akashi M, Mitamura H, Ogawa S: C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 1997;96:778-784
9. Morishima I, Sone T, Tsuboi H, Kondo J, Mukawa H, Kamiya H, Hieda N, Okumura K: Plasma C-reactive protein predicts left ventricular remodeling and function after a first acute anterior wall myocardial infarction treated with coronary angioplasty: Comparison with brain natriuretic peptide. Clin Cardiol 2002;25:112-116
10. Maekawa Y, Anzai T, Yoshikawa T, Asakura Y, Takahashi T, Ishikawa S, Mitamura H, Ogawa S: Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: A possible role for left ventricular remodeling. J Am Coll Cardiol 2002; 39:241-246
11. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S: Cytokine gene expression after myocardial infarction in rat hearts. Possible implication in left ventricular remodeling. Circulation 1998;98:149-156
12. Prabhu SD, Chandrasekar B, Murray DR, Freeman GL: β-Adrenergic blockade in developing heart failure. Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 2000;101: 2103-2109
13. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E: Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000;101:2149-2153
14. Kotajima N, Kimura T, Kanda T, Kuwabara A, Fukumura Y, Murakami M, Kobayashi I: Reciprocal increase of circulating interleukin-10 and interleukin-6 in patients with acute myocardial infarction. Heart 2001;86: 704-705
15. Jacobs M, Staufenberger S, Gergs U, Meuter K, Brandstatter K, Hafner M, Ertl G, Schorb W: Tumor necrosis factor-alpha at acute myocardial infarction in rats and effects on cardiac fibroblast. J Mol Cell Cardiol 1999;31:1949-1959
16. Jeremias I, Kupatt C, Martin-Villalba A, Habazettl H, Schenkel J, Boekstegers P, Debatin KM: Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. Circulation 2000;102:915-920
17. Ohtsuka T, Hamada M, Hiasa G, Sasaki O, Suzuki M, Hara Y, Shigematsu Y, Hiwada K: Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy. J Am Coll Cardiol 2001;37:412-417
18. Nagaya N, Nishikimi T, Goto Y, Miyao Y, Kobayashi Y, Morii I, Daikoku S, Matsumoto T, Miyazaki S, Matsuoka H, Takishita S, Kangawa K, Matsuo H, Nonogi H: Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after myocardial infarction. Am Heart J 1998;135:21-28
19. Furman MI, Becker RC, Yarzebski J, Savegeau J, Gore JM, Goldberg RJ: Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. Am J Cardiol 1996;78:945-948
20. Ikeda U, Ohkawa F, Seino Y, Yamamoto K, Hidaka Y, Kasahara T, Kawai T, Shimada K: Serum interleukin 6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol 1992:24:579-584
21. Chandrasekar B, Mitchell DA, Colston JT, Freeman GL: Regulation of CCAAT/enhancer binding protein, interleukin-6, interleukin-6 receptor, and gp130 expression during myocardial ischemia/reperfusion. Circulation 1999;99:427-433